BioMarin Expands Enzyme Therapies Portfolio with Inozyme Acquisition
BioMarin Pharmaceutical Inc. has entered into a definitive agreement to acquire clinical-stage biotech Inozyme Pharma, Inc. for approximately $270 million
Read moreBioMarin Pharmaceutical Inc. has entered into a definitive agreement to acquire clinical-stage biotech Inozyme Pharma, Inc. for approximately $270 million
Read moreThe CTAT Enzymatic Antibody Drug Conjugation Technology -Benefits for Diagnostic Applications and ADC’s for Oncology. A Biosynth Case Study This
Read moreApplication-driven enzyme engineering is a new technology created by combining in silico modelling and wet-lab based enzyme screening that is
Read moreBiosynth provides top-tier enzyme solutions tailored to specific needs in biopharma, biotech, and applied sectors. Leveraging advanced enzyme engineering techniques,
Read moreThe Lysozyme HCI from Chicken Egg White, available from GERBU, is a versatile enzyme for your research or industrial needs.
Read moreGERBU offers high-quality Ribonuclease A (RNase A) in ≥70U/mg and ≥100U/mg as a freeze-dried powder or as a solution upon
Read moreGERBU offers high-quality Proteinase K Solution, RNase/DNase free, ≥800U/ml, 20mg/ml. This Proteinase K solution has been purified and tested for
Read moreBiosynth specialises in Chemical Synthesis and Contract Development and Manufacturing Organization (CDMO) services, providing a comprehensive range of bulk and
Read moreBiosynth provides an exceptional range of chemicals, peptides and biochemicals, offering scientists and researchers worldwide unparalleled convenience, choice, and dependability.
Read moreThe Proteinase K solution (20mg/mL) for PCR applications, manufactured by Genaxxon, is a non-specific serine protease with very high specific
Read more